Glen Eagle Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $122K | Sell |
|
|||||
|
2025
Q2 | $393K | Sell |
|
|||||
|
2025
Q1 | $508K | Sell |
|
|||||
|
2024
Q4 | $986K | Sell |
|
|||||
|
2024
Q3 | $1.4M | Buy |
|
|||||
|
2024
Q2 | $1.52M | Buy |
|
|||||
|
2024
Q1 | $1.16M | Buy |
|
|||||
|
2023
Q4 | $802K | Sell |
|
|||||
|
2023
Q3 | $1.04M | Buy |
|
|||||
|
2023
Q2 | $192K | Buy |
|
|||||
|
2023
Q1 | $3.34K | Sell |
|
|||||
|
2022
Q4 | $3.11K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.44K | Sell |
|
|||||
|
2021
Q4 | $12.7K | Sell |
|
|||||
|
2021
Q3 | $48K | Hold |
|
|||||
|
2021
Q2 | $41.9K | Hold |
|
|||||
|
2021
Q1 | $33.7K | Hold |
|
|||||
|
2020
Q4 | $34.9K | Hold |
|
|||||
|
2020
Q3 | $34.7K | Sell |
|
|||||
|
2020
Q2 | $33.2K | Buy |
|
|||||
|
2020
Q1 | $30.1K | Buy |
|
|||||
|
2019
Q4 | $27.5K | Buy |
|
|||||
|
2019
Q3 | $20.7K | Hold |
|
|||||
|
2019
Q2 | $20.4K | Hold |
|
|||||
|
2019
Q1 | $20.9K | Hold |
|
|||||
|
2018
Q4 | $18.4K | Hold |
|
|||||
|
2018
Q3 | $18.9K | Hold |
|
|||||
|
2018
Q2 | $18.4K | Hold |
|
|||||
|
2018
Q1 | $19.7K | Sell |
|
|||||
|
2017
Q4 | $37.6K | Hold |
|
|||||
|
2017
Q3 | $33.7K | Sell |
|
|||||
|
2017
Q2 | $50.4K | Hold |
|
|||||
|
2017
Q1 | $40.3K | Buy |
|
|||||
|
2016
Q4 | $31.4K | Buy |
|